FTSE finishes slightly lower despite positive vaccine news

Writer,

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

A surge in US Covid-19 cases and tensions over Hong Kong outweighed some positive vaccine news on Wednesday, with the FTSE 100 finishing modestly lower.

Helping to arrest the blue chip benchmark's earlier plunge was the news a potential vaccine from German company BioNtech and Pfizer 'yields immune activity and a strong immune response' and will now move on to wider trials.

The FTSE 100 finished the session down 11.78 points, or 0.19% lower, at 6,157.96.

LARGE AND MID CAP RISERS AND FALLERS

Supermarket group J Sainsbury softened 2.6% to 203.2p despite sales in the first quarter, excluding fuel, jumping 8.5% as households stocked up during Covid-19 lockdowns.

Sainsbury's, however, said it still expected its annual profits to be flat, owing to increased costs associated with making its stores safer and hiring extra staff to meet demand. Falling demand for petrol would also hurt its bottom line.

General merchandise discounter B&M European Value Retail ended the session 4.9% higher at 417p after reporting a better than expected rise in first quarter sales, which showed June trading ticked up from already elevated levels.

Travel hub convenience store group SSP dropped 2.3% to 251.4p on revealing that it could make up to 5,000 of its staff redundant due to the lingering impact of the Covid-19 crisis on demand for travel.

Medical technology group Smith & Nephew gained 5% to £15.81, even as it said it expected its underlying revenue to sink by around 29% in the second quarter.

On the positive side, Smith & Nephew said the revenue picture had improved as the quarter progressed, with declines of 47% in April, 27% in May and 12% in June.

Aerospace and defence company Babcock International rose 2.4% to 317.7p on announcing that had appointed David Lockwood as chief executive.

Lockwood was previously CEO of defence group Cobham.

Component supplier to the defence and aerospace sectors Meggitt rose 3.7% to 305.1p after it sold its training systems unit to US private equity firm Pine Island Capital Partners for $146m.

Infrastructure investor John Laing slumped 10.5% to 311.8p, having warned its net asset value for the first half was expected to show a single-digit decline, as investment activity stalled amid the pandemic.

German business park investor Sirius Real Estate rose 2.1% to 77.8p on announcing that it collected almost all of rent due in June following a relaxation of Covid-19 lockdowns.

Sirius reiterated that it would pay a dividend of 1.8c per share for the second half of the financial year through March 2020, with the payout to be made on 20 August.

SMALL CAP RISERS AND FALLERS

Flooring retailer Topps Tiles rallied 8.1% to 48p despite its average weekly sales slumping 53% in the third quarter of its financial year.

Topps Tiles said the subdued performance was nevertheless better than it had expected and that the depth of declines had improved by June.

Subprime lender Provident Financial fell 1.3% to 173.9p on announcing that the head of its consumer credit division, Chris Gillespie, was leaving to join pawnbroker H&T.

Gillespie had been replaced, subject to regulatory approval, by Hamish Paton, who was briefly chief executive of Amigo between July and December last year.

Cello Health surged 44.6% higher to 162p after receiving and recommending a £178.8 million all-cash takeover offer from Value Demonstration.